New combo meningitis shot shows promise in teen trial

NCT ID NCT05087056

First seen Apr 15, 2026 · Last updated May 14, 2026 · Updated 3 times

Summary

This study is testing a new vaccine called MenABCWY that aims to protect against five types of meningitis bacteria (A, B, C, W, and Y) in one shot. About 312 healthy teenagers will receive the vaccine on different schedules to check for safety and how well their immune system responds. The goal is to find a simpler way to prevent this serious infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENINGITIS, MENINGOCOCCAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GSK Investigational Site

    Tucson, Arizona, 85745, United States

  • GSK Investigational Site

    Ventura, California, 93003, United States

  • GSK Investigational Site

    Macon, Georgia, 31210, United States

  • GSK Investigational Site

    Valparaiso, Indiana, 84088, United States

  • GSK Investigational Site

    Missoula, Montana, 80216, United States

  • GSK Investigational Site

    Charlotte, North Carolina, 28226, United States

Conditions

Explore the condition pages connected to this study.